Fremont, CA, United States of America

Sambaiah Thota

USPTO Granted Patents = 42 

 

 

Average Co-Inventor Count = 8.7

ph-index = 13

Forward Citations = 488(Granted Patents)


Location History:

  • Woburn, MA (US) (2011 - 2015)
  • Fremont, CA (US) (2008 - 2017)
  • Union City, CA (US) (2019 - 2023)

Company Filing History:


Years Active: 2008-2023

Loading Chart...
Loading Chart...
Loading Chart...
42 patents (USPTO):

Title: **Sambaiah Thota: Innovator in JAK Pathway Modulation**

Introduction

Sambaiah Thota, based in Fremont, CA, is a distinguished inventor in the field of pharmaceutical sciences. With an impressive portfolio of 42 patents, he has significantly advanced the understanding and treatment of conditions that involve the JAK signaling pathway. His work primarily focuses on the development of novel compounds that interact with JAK kinases, a critical component in various disease mechanisms.

Latest Patents

Among his latest contributions are two notable patents focused on the inhibition of the JAK pathway. The first patent encompasses compositions and methods for the inhibition of JAK kinases, particularly JAK3, targeting conditions where modulation of this pathway may offer therapeutic benefits. The second patent also covers similar compounds and methods, further reinforcing the importance of JAK3 in medical treatments.

Career Highlights

Sambaiah Thota is currently affiliated with Rigel Pharmaceuticals, Incorporated, a company dedicated to advancing innovative medicines for patients with unmet medical needs. His career is marked by a strong emphasis on therapeutic developments aimed at addressing chronic diseases and inflammatory conditions through innovative chemical compositions.

Collaborations

Throughout his career, Thota has collaborated with notable coworkers, including Rajinder Paul Singh and Hui Li. Together, they have contributed to the advancement of therapeutic strategies that leverage the JAK pathway for improved patient outcomes. Their collaborative efforts reflect the spirit of innovation that drives the pharmaceutical industry forward.

Conclusion

Sambaiah Thota exemplifies the role of inventors in the continuous pursuit of medical advancements. With his extensive patent portfolio and significant collaborations, he remains a key figure in the innovation landscape, particularly in the modulation of the JAK pathway, ensuring that new therapeutic options are available for those in need.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…